Molecular physiology of glucagon-like peptide-1 insulin secretagogue action in pancreatic β cells
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Insulin secretion from pancreatic β cells is stimulated by glucagon-like peptide-1 (GLP-1), a blood glucose-lowering hormone that is released from enteroendocrine L cells of the distal intestine after the ingestion of a meal. GLP-1 mimetics (e.g., Byetta) and GLP-1 analogs (e.g., Victoza) activate the β cell GLP-1 receptor (GLP-1R), and these compounds stimulate insulin secretion while also lowering levels of blood glucose in patients diagnosed with type 2 diabetes mellitus (T2DM). An additional therapeutic option for the treatment of T2DM involves the administration of dipeptidyl peptidase-IV (DPP-IV) inhibitors (e.g., Januvia, Galvus). These compounds slow metabolic degradation of intestinally released GLP-1, thereby raising post-prandial levels of circulating GLP-1 substantially. Investigational compounds that stimulate GLP-1 secretion also exist, and in this regard a noteworthy advance is the demonstration that small molecule GPR119 agonists (e.g., AR231453) stimulate L cell GLP-1 secretion while also directly stimulating β cell insulin release. In this review, we summarize what is currently known concerning the signal transduction properties of the β cell GLP-1R as they relate to insulin secretion. Emphasized are the cyclic AMP, protein kinase A, and Epac2 mediated actions of GLP-1 to regulate ATP-sensitive K+ channels, voltage-dependent K+ channels, TRPM2 cation channels, intracellular Ca2+ release channels, and Ca2+-dependent exocytosis. We also discuss new evidence that provides a conceptual framework with which to understand why GLP-1R agonists are less likely to induce hypoglycemia when they are administered for the treatment of T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Triggering and amplifying pathways of regulation of insulin secretion by glucose.
Henquin, J. C. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1751 · Cited by 1,201 · cited 2×
“Since first phase GSIS is primarily a KATP channel dependent mechanism of exocytosis (Henquin, 2000), and since the KO of Epac2 disrupts first phase GSIS, it could be that under true physiological conditions, the primary role of Epac2 is to mediate cAMP-dependent closure of KATP channels, thereby depolarizing b cells.”
BackgroundNAADP mobilizes calcium from acidic organelles through two-pore channels
Calcraft, P. J., Ruas, M., Pan, Z., Cheng, X., Arredouani, A., Hao, X., Tang, J., Rietdorf, K., Teboul, L., Chuang, K.-T., et al. (2009) · Nature · doi:10.1038/nature08030 · Cited by 760 · cited 1×
“NAADP is a Ca2þ-mobilizing metabolite that is reported to bind to and stimulate the opening of “two-pore” Ca2þ channels (TPCs) (Calcraft et al., 2009; Naylor et al., 2009).”
BackgroundcAMP-GEFII is a direct target of cAMP in regulated exocytosis
Ozaki, N., Shibasaki, T., Kashima, Y., Miki, T., Takahashi, K., Ueno, H., Sunaga, Y., Yano, H., Matsuura, Y., Iwanaga, T., et al. (2000) · Nature Cell Biology · doi:10.1038/35041046 · Cited by 481 · cited 2×
“, 2002), but also Epac2, a novel cAMP-binding protein that interacts directly with nucleotide binding-fold 1 (NBF-1) of the sulfonylurea receptor 1 (SUR1) subunit of KATP channels (Kang et al., 2006, 2008; Ozaki et al., 2000; Shibasaki et al., 2004b).”
BackgroundRenström, E., Eliasson, L., & Rorsman, P. (1997) · The Journal of Physiology · doi:10.1111/j.1469-7793.1997.105bl.x · Cited by 299 · cited 7×
“Glucose metabolism in the b cell elevates the cytosolic ATP/ADP concentration ratio and closes ATP-sensitive Kþ channels (KATP) resulting in b cell depolarization, Ca2þ influx through voltage-dependent Ca2þ channels (VDCCs), and Ca2þ-dependent exocytosis of insulin.”
BackgroundInfluentialKang, G., Joseph, J. W., Chepurny, O. G., Monaco, M., Wheeler, M. B., Bos, J. L., Schwede, F., Genieser, H.-G., & Holz, G. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211682200 · Cited by 298 · cited 3×
“Ca2þ released in this manner serves as a direct stimulus for exocytosis in b cells (Dyachok and Gylfe, 2004; Kang and Holz, 2003; Kang et al., 2003).”
BackgroundSelf-citationHare, K. J., Vilsbøll, T., Asmar, M., Deacon, C. F., Knop, F. K., & Holst, J. J. (2010) · Diabetes · doi:10.2337/db09-1414 · Cited by 276 · cited 1×
“Administered GLP-1R analogs act at pancreatic a cells to inhibit glucagon secretion, and this effect is accompanied by a suppression of hepatic glucose production (Hare et al., 2010).”
BackgroundSUR1 Regulates PKA-independent cAMP-induced Granule Priming in Mouse Pancreatic B-cells
Eliasson, L., Ma, X., Renström, E., Barg, S., Berggren, P.-O., Galvanovskis, J., Gromada, J., Jing, X., Lundquist, I., Salehi, A., et al. (2003) · The Journal of General Physiology · doi:10.1085/jgp.20028707 · Cited by 257
Barg, S., Eliasson, L., Renström, E., & Rorsman, P. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s74 · Cited by 227 · cited 7×
“Glucose metabolism in the b cell elevates the cytosolic ATP/ADP concentration ratio and closes ATP-sensitive Kþ channels (KATP) resulting in b cell depolarization, Ca2þ influx through voltage-dependent Ca2þ channels (VDCCs), and Ca2þ-dependent exocytosis of insulin.”
BackgroundInfluentialGlucose-Induced Cyclic AMP Oscillations Regulate Pulsatile Insulin Secretion
Dyachok, O., Idevall-Hagren, O., Sågetorp, J., Tian, G., Wuttke, A., Arrieumerlou, C., Akusjärvi, G., Gylfe, E., & Tengholm, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.003 · Cited by 193
Holz, G. G., Leech, C. A., & Habener, J. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.30.17749 · Cited by 188 · cited 2×
“Note that in this experiment, a train of action potentials was superimposed on a plateau depolarization (for methods, see (Holz et al., 1995)).”
BackgroundMethodSelf-citation
Cited by
Diabetes Mellitus and the β Cell: The Last Ten Years
Ashcroft, F. M., & Rorsman, P. (2012) · Cell · doi:10.1016/j.cell.2012.02.010 · Cited by 902
Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men
Rorsman, P., & Ashcroft, F. M. (2018) · Physiological Reviews · doi:10.1152/physrev.00008.2017 · Cited by 793
Meloni, A. R., DeYoung, M. B., Lowe, C., & Parkes, D. G. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01663.x · Cited by 407
Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
Rowlands, J., Heng, J., Newsholme, P., & Carlessi, R. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00672 · Cited by 302
Regulation of Glucose Homeostasis by GLP-1
Nadkarni, P., Chepurny, O. G., & Holz, G. G. (2014) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-800101-1.00002-8 · Cited by 287
Self-citation
Metadata
- Authors
- Leech, C. A., Dzhura, I., Chepurny, O. G., Kang, G., Schwede, F., Genieser, H.-G., & Holz, G. G.
- Venue
- Progress in Biophysics and Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 107
- Issue
- 2
- Pages
- 236-247
- ISSN
- 0079-6107 (ISSN-L)
- OpenAlex
- W2046913589
- Cited by
- 128
- References
- 14
- FWCI
- 11.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular physiology of glucagon-like peptide-1 insulin secretagogue action in pancreatic β cells. https://app.cochat.ai/papers/10.1016/j.pbiomolbio.2011.07.005
- The paper
- Leech, C. A., Dzhura, I., Chepurny, O. G., Kang, G., Schwede, F., Genieser, H.-G., & Holz, G. G. (2011). Molecular physiology of glucagon-like peptide-1 insulin secretagogue action in pancreatic β cells. Progress in Biophysics and Molecular Biology. https://doi.org/10.1016/j.pbiomolbio.2011.07.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.